# Virgo-Meds reviews (2026): GLP-1 telehealth sellers | This GLP

Virgo names OpenLoop and describes four-week check-ins while the dose is being established.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/virgo-meds
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated October 2026 Clinical group identified

# Virgo-Meds review

Virgo names OpenLoop and describes four-week check-ins while the dose is being established.

## The verdict

Virgo describes both the clinical network and an early check-in cadence; clarify how monitoring changes once the dose is stable.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection · Oral

Prescription

Required

Compounded

Yes — not FDA-approved

Virgo-Meds offers online compounded weight-loss prescriptions with injectable and oral options. The public process describes a medical assessment, state-dependent consultation, pharmacy delivery and check-ins while the dose is being established.

1.  ## Who writes the prescription, and what do they see?
    
    The terms identify OpenLoop and affiliated professional medical groups as clinical providers. Most evaluations are asynchronous, with a live video visit where required. The clinician decides whether prescribing is appropriate after reviewing the full health history.
    
    Virgo describes check-ins every four weeks while the dose settles, then less often, with messaging or video contact available. Ask what triggers the reduced review frequency and how to obtain a clinical response if symptoms arise between contacts.
    
2.  ## What happens when the dose goes up?
    
    The program describes dose adjustments based on response. Agree on the exact ingredient, route and milligrams with the prescriber rather than using a shared schedule for oral and injectable products.
    
3.  ## What the price includes
    
    The current homepage promotes a discount, but the full selected plan and renewal total need confirming. The terms govern subscriptions and refund timing. The stated no-approval refund should not be mistaken for a refund of medication already prepared or shipped.
    
4.  ## What it claims, and what it cites
    
    The site markets [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) and [tirzepatide](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) in different formulations. Compounded medicines are not FDA-approved; a dissolving oral product should not be assumed to share an injection’s absorption, dose or clinical evidence.
    

## Where it holds up, and where it does not

-   Strength: Clinical group identified
-   Strength: Four-week early check-ins described
-   Strength: State-dependent video visits explained
-   Limitation: Review frequency becomes less specific after stabilization
-   Limitation: Discount does not establish the full recurring bill
-   Limitation: Oral and injected formats need separate comparison

## What the evidence says about this kind of treatment

The assessment above is about Virgo-Meds. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

Someone who wants online prescribing with a described early monitoring period and can confirm when a live visit is needed.

Wrong for

Someone who needs the same fixed clinical review frequency throughout treatment rather than less frequent contact after stabilization.

## The evidence behind what Virgo-Meds prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Virgo-Meds compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate |  |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one |  |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [OurView Health](https://thisglp.com/reviews/ourview-health) [Oxford's Medical Weight Loss (The Calibrate Clinic)](https://thisglp.com/reviews/the-calibrate-clinic)[Ozari Health](https://thisglp.com/reviews/ozari-health) [Pallas Health](https://thisglp.com/reviews/pallas-health) [PauseRX](https://thisglp.com/reviews/pauserx) [PCOS Sisters](https://thisglp.com/reviews/pcos-sisters)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

What should I confirm about ongoing care?

Virgo describes check-ins every four weeks while the dose settles, then less often, with messaging or video contact available. Ask what triggers the reduced review frequency and how to obtain a clinical response if symptoms arise between contacts. Ask who makes clinical decisions between refills and how to reach that person.

Is a prescription guaranteed?

No. An independent licensed clinician must decide whether treatment is appropriate; a product page or completed intake does not establish eligibility.

## Sources for this review

Provider information checked October 26, 2026. Terms can change.

-   [Clinical process and check-ins](https://virgo-meds.com/pages/how-it-works)
-   [Medical group and subscription terms](https://virgo-meds.com/policies/terms-of-service)
-   [Weight-loss treatments](https://virgo-meds.com/pages/weight-loss)

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
